Lōvu Health is a next-generation digital platform dedicated to transforming maternal outcomes through technology, service, and data.
Lōvu Health ensures every expectant mother and her baby can equitably access precision care guided by innovative technology and evidence-based insights. Clinicians are able to monitor patients more closely and intervene earlier when necessary, while Lōvu's proprietary recommendation engine helps providers improve patient outcomes and satisfaction.
Read MoreEma is an AI-powered assistant designed to support women's health across all life stages.
Ema offers personalized, evidence-based guidance on topics ranging from menstruation to menopause and seamlessly integrating with businesses to deliver tailored resources and actionable data insights. Ema empowers women and their families to take control of their health while seamlessly integrating with businesses to deliver tailored resources and actionable data insights.
Read MoreIntegrating precision medicine with women's mental health for every life stage.
LunaJoy is integrating precision medicine with women's mental health to power a digital mental health clinic specialized in every life stage including adolescence, pregnancy, postpartum, infertility, miscarriage, menopause, and aging. LunaJoy provides therapy, medication management, coaching, genetic testing, and support groups via DTC and B2B offerings, all integrated with a woman’s primary care and supported by insurance.
Read MorePowering innovation, behavioral change, and empowerment across the sexual health & technology industry.
Healthy Pleasure Group is the only global outfit w/ the required combination of R&D, agency, and learning capabilities to harness market growth and lead positive behavioral change. With a team of specialists (scientists, marketers, and educators), an IP vault of 20+ ready-to-market products, and serving 60+ clients across four continents, HPG is revolutionizing sexual health & technology through the economic engines of education,product innovation, and investment.
Read MoreClosing the gap on maternal and postpartum outcomes for Black women by unlocking community and certifying culturally competent care.
She Matters is a digital health platform designed to provide Black women with community, culturally relevant resources, and culturally competent therapists as they navigate their postpartum experience. She Matters trains therapists and healthcare professionals to be better resources for Black mamas, by ensuring they are aware of the healing challenges faced by Black women and removing the cultural stigma and medical neglect associated with mental illness in the Black community.
Read MoreInnovating athletic apparel with feminine wellness in mind.
OYA is transforming the technology behind women’s athletic apparel to deliver better ventilation and moisture control where it matters most. In partnership with OB/GYNs, OYA developed a line of athletic apparel with patent-pending ventilation panels and leak absorbent crotch gusset technology to keep vaginas dry and clean, and anti-chafing elastic bands to reduce the likelihood of breast rashes. OYA is making constant OB visits for everyday and pro athletic women a thing of the past.
Read MoreUsing VR to manage pain and anxiety.
Using 30 years of clinical studies, Flowly is redefining how everyday people learn to live with chronic pain, anxiety, and trouble sleeping. Using responsive VR environments, biofeedback training for relaxation, and therapeutic voice-over and music, Flowy is helping users regulate their Autonomic Nervous System without medication. Trusted by world-class hospital systems and academic institutions, and the subject of ongoing NIH studies, Flowly is changing the face of chronic pain management.
Read MoreBringing safety to home dialysis.
Relavo is enriching the lives of people with kidney failure by making home dialysis safer and more accessible by changing the way those on Peritoneal Dialysis (PD) receive care. With patent-protected technology called PeritoneX, Relavo has created a solution to internally disinfect dialysis tubes at all connection sites in the PD system. Relavo is guided by patient-centric decision making, a people-first mentality, a willingness to learn, and a focus on diversity and inclusion.
Read MoreBridging the diversity gap for clinical trials.
Infiuss is expanding under-represented access to clinical trials through the power of technology, starting with West Africa. Through remote enrollment and participant qualification, Infiuss is ensuring large pharma can deliver equity and representation across their clinical trials – ensuring higher quality care and outcomes for everyone.
Read MoreSaving half the women diagnosed with ovarian cancer.
AOA has developed the first liquid biopsy test that accurately enables the early diagnosis of ovarian cancer through the analysis of tumor marker gangliosides. With approx. 80% of ovarian cancer cases only detected at stages III and IV, AOA provides the potential to reduce the number of deaths from this diagnosis by half, significantly reduce the costs of treatment and recurrence, and save countless women’s lives.
Read More
